---
title: "=====\n\nSYNERGY: Empagliflozin has received a drug registration certificate in South Korea\n\n====="
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/228833242.md"
description: "According to the Zhitong Finance APP, SYNERGY announced that the company recently received the drug registration certificate for Empagliflozin issued by the Ministry of Food and Drug Safety (MFDS) of South Korea, which is suitable for the treatment of type 2 diabetes"
datetime: "2025-02-19T09:53:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/228833242.md)
  - [en](https://longbridge.com/en/news/228833242.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/228833242.md)
generator: "portal-rs"
---

# =====

SYNERGY: Empagliflozin has received a drug registration certificate in South Korea

=====

According to the Zhitong Finance APP, SYNERGY (300636.SZ) announced that the company recently received the drug registration certificate for Empagliflozin issued by the Ministry of Food and Drug Safety (MFDS) of South Korea, which is suitable for the treatment of type 2 diabetes

### Related Stocks

- [300636.CN](https://longbridge.com/en/quote/300636.CN.md)

## Related News & Research

- [Chinese Pharma Companies Plan Hong Kong Listings](https://longbridge.com/en/news/297979501.md)
- [Clinica Baviera CEO Luis Gravalos sells EUR 214,200 of shares](https://longbridge.com/en/news/297510084.md)
- [DAZN partners with SENSHI to stream kickboxing events worldwide for free](https://longbridge.com/en/news/298082089.md)
- [15:12 ETTGI Fridays™ Signs Landmark Development Agreement with Devolli Group, Accelerating Global Growth with First-Ever Expansion into the Balkans](https://longbridge.com/en/news/298068531.md)
- [Teqnion agrees to acquire Scotland-based Abercromby Vending](https://longbridge.com/en/news/297759475.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**